Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.
1. STOCK NEWS:
- Altria (MO) agreed to acquire NJOY Holdings for $2.75B in cash [read more]
- Silvergate Capital (SI) announced that it has discontinued the Silvergate Exchange Network [read more]
- Amazon's (AMZN) "Creed III" won the weekend domestic box office with a better-than-expected $58.7M [read more]
- JetBlue (JBLU) said that updated data supports the "pro-competitive impact" of its proposed Spirit (SAVE) deal after reports indicated JetBlue is bracing for a DOJ lawsuit to block the merger [read more]
- California Governor Gavin Newsom said the state is "done" with Walgreens (WBA) over the company's abortion pill stance [read more]
2. WALL STREET CALLS:
- Apple (AAPL) initiated with a Buy at Goldman Sachs [read more]
- Monster Beverage (MNST) upgraded to Buy from Neutral at Redburn [read more]
- Vir Biotechnology (VIR) upgraded to Overweight from Neutral at JPMorgan [read more]
- Silvergate Capital (SI) downgraded to Underperform at Wedbush and to Sell at Compass Point [read more]
- RH (RH) cut to Hold at Jefferies with luxury housing market "struggling to stabilize" [read more]
3. AROUND THE WEB:
- Proxy advisers are urging shareholders to reject Ritchie Bros' (RBA) bid for IAA (IAA), Reuters reports [read more]
- Sirius XM (SIRI) is laying off 8% of its workforce, The Hollywood Reporter says [read more]
- Kerrisdale is short on C3.ai (AI) on "poor customer traction" [read more]
- Caterpillar (CAT) won't close union plants under a new contract, WSJ reports [read more]
- Paramount (PARA) is exploring the sale of a majority stake in BET, WSJ says [read more]
4. MOVERS:
- BridgeBio (BBIO) gain after announcing Phase 2 cohort 5 results of infigratinib [read more]
- Vistra (VST) advances after announcing it will acquire Energy Harbor (ENGH) for $3B in cash [read more]
- Qualtrics (XM) higher after Silver Lake offered $18.15 per share in cash for the remaining shares the firm does not already own [read more]
- Aclaris Therapeutics (ACRS) lower after announcing preliminary data from Phase 2 study of ATI-450 [read more]
- Esperion (ESPR) lower after announcing full results from its CLEAR outcomes study [read more]
5. EARNINGS/GUIDANCE:
- Ciena (CIEN) reported better-than-expected Q1 results [read more]
- BlackLine (BL) reaffirmed its Q1 and FY23 guidance [read more]
- Valaris (VAL) provided an adjusted EBITDA outlook for Q1 and FY23 [read more]
- Lordstown Motors (RIDE) reported a year-over-year decline in Q4 earnings [read more]
- CECO Environmental (CECO) provided a "beat and raise" report for Q4 [read more]
INDEXES:
The Dow rose 40.47, or 0.12%, to 33,431.44, the Nasdaq lost 13.27, or 0.11%, to 11,675.74, and the S&P 500 advanced 2.78, or 0.07%, to 4,048.42.